Publications by authors named "Anna Di Benedetto"

39Publications

Aberrant transcriptional and post-transcriptional regulation of SPAG5, a YAP-TAZ-TEAD downstream effector, fuels breast cancer cell proliferation.

Cell Death Differ 2020 Nov 23. Epub 2020 Nov 23.

Oncogenomic and Epigenetic Unit, Department of Research, Diagnosis and Innovative Technologies, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41418-020-00677-9DOI Listing
November 2020

Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study.

J Exp Clin Cancer Res 2018 May 2;37(1):95. Epub 2018 May 2.

Department of Research, Advanced Diagnostics and Technological Innovation, Genomic and Epigenetic Unit, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13046-018-0768-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930939PMC
May 2018

Molecular genetic alterations in egfr CA-SSR-1 microsatellite and egfr copy number changes are associated with aggressiveness in thymoma.

J Thorac Dis 2016 Mar;8(3):386-95

1 Department of Pathology, Regina Elena National Cancer Institute, Rome, Italy ; 2 Thoracic Surgery, Regina Elena National Cancer Institute, Rome, Italy ; 3 Rare Tumors Reference Center, Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy ; 4 Pathology, Catholic University, Rome, Italy ; 5 Department of Neurosciences, Catholic University, Rome, Italy ; 6 Division of Health Technologies-ENEA C.R. Casaccia, Rome, Italy ; 7 Biostatistic Unit, Regina Elena National Cancer Institute, Rome, Italy ; 8 Thoracic Surgery, Catholic University, Rome, Italy ; 9 Department of Oncology, Faculty of Health Science, McMaster University, Hamilton, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2016.02.40DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805790PMC
March 2016

Androgen receptor and antiandrogen therapy in male breast cancer.

Cancer Lett 2015 Nov 11;368(1):20-25. Epub 2015 Aug 11.

Division of Medical Oncology B, "Regina Elena" National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy; Scientific Direction, "Regina Elena" National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2015.07.040DOI Listing
November 2015

ATM kinase sustains HER2 tumorigenicity in breast cancer.

Nat Commun 2015 Apr 16;6:6886. Epub 2015 Apr 16.

1] Laboratory of Cell Signaling, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione Santa Lucia, 00179 Rome, Italy [2] Department of Biology, University of Rome 'Tor Vergata', 00133 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms7886DOI Listing
April 2015

Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series.

Breast Cancer Res Treat 2014 Nov 20;148(1):73-80. Epub 2014 Sep 20.

Division of Medical Oncology B, "Regina Elena" National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-3138-9DOI Listing
November 2014

High-mobility group A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic activator HIPK2.

J Clin Invest 2007 Mar 8;117(3):693-702. Epub 2007 Feb 8.

Dipartimento di Biologia e Patologia Cellulare e Molecolare, Facoltà di Medicina e Chirurgia, Università degli Studi di Napoli Federico II, Naples, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI29852DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1784001PMC
March 2007